Smart Vitamins — Seed (estimated) · €2.1M

The CiMUS/USC spin-off raised €2.1 million from a group of strategic business angels to fund the first human clinical trial of SV B-I, a nasal-spray flu-prevention therapy built on its Smart Delivery of Nutrients platform. No lead investor was named; the trial is planned to start in the UK in early 2026.

Something wrong? Suggest a correction →